In addition, alkyl/alkenyl-EL, some of which belong to a new class of SK3 modulators, could be used in clinical applications as inhibitors of bone metastases and the peripheral neuropathic effect of chemotherapeutic agents in cancer or for specific neurodegenerative and cardiovascular diseases. Here, KCNN3 is linked to cardiovascular disorder.